Back to search

University of Edinburgh

Imaging biomarker exploration and tissue validation in translational neuro-oncology

Abstract

dc:description.abstract

Glioblastoma (GBM) is the most common and aggressive primary brain tumour, with me-dian survival of approximately 15 months having seen only modest improvements over two decades despite numerous clinical trials. The inter- and intra-tumoural microenvironmental heterogeneity and infiltrative growth pattern pose significant challenges for treatment planning and response monitoring. The limited progress has been attributed in part to the absence of robust biomarkers capable of characterising treatment resistance and disease infiltration. Non-invasive imaging biomarkers that can capture tumour heterogeneity and extent are there-fore critically important, yet traditional biological validation approaches compare imaging para-meters with small, targeted histopathological samples using a limited number of hypothesis-driven tissue markers. Given these challenges, biological validation is often eschewed in favour of correlative studies comparing summary imaging metrics to clinical outcomes such as overall survival. This approach masks spatial heterogeneity, provides only averaged information, introduces selection bias, and constrains discovery. Consequently, modern pharmaceutical trials continue to rely on limited imaging readouts such as linear response assessments of tumour size proxies. This thesis develops a methodological framework for voxel-based integration of high-plex spatial biology with multiparametric imaging, enabling spatially-resolved discovery, exploration, and validation of imaging biomarkers. The methodology comprises: (1) voxel-level analysis matching cross-sectional imaging to tissue samples in preclinical models while preserving spatial heterogeneity; (2) generation of ’pseudo-PET’ and ’pseudo-MRI’ parametric maps from spatially-resolved two-dimensional tissue sections, enabling direct statistical comparison between molecular and imaging data; (3) three-dimensional tissue-to-MRI registration using light-sheet microscopy; and (4) integration of expression data from over 1,000 genes with individual MRI and PET voxels at single-cell resolution using spatial transcriptomics. In murine GBM models, key findings include: a consistent negative relationship between pericytes density and the blood-brain barrier permeability parameter Ktrans, with voxels in lower pericytes quartiles demonstrating significantly elevated Ktrans values; evidence that manganese-based MRI contrast agents correlate with glioblastoma cell density in a way not achieved by gadolinium based agents; identification of multifactorial determinants of [18F]FET-PET uptake; and validation of margin diffusion slope as an infiltration biomarker associated with survival.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Içer, Yusuf
Advisors dc:contributor.advisor
  • Thompson, Gerry
  • Waldman, Adam

Subjects

dc:subject × 5

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Edinburgh
Base URL
era.ed.ac.uk/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Içer, Yusuf. Imaging biomarker exploration and tissue validation in translational neuro-oncology. 2026. https://era.ed.ac.uk/handle/1842/45014